PHARMA Duro 30 (30pc)
R650,00
DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of
morbidity from other medical conditions is increased. P
Guarantee safe & secure checkout
Description
DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of
morbidity from other medical conditions is increased.
Quick Comparison
| PHARMA Duro 30 (30pc) remove | FEI Retat 32.5 remove | HDL Retat 32 remove | BP GHK-CU 50 remove | BP Retat 32 remove | HDL Tirze 30 remove | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PHARMA Duro 30 (30pc) remove | FEI Retat 32.5 remove | HDL Retat 32 remove | BP GHK-CU 50 remove | BP Retat 32 remove | HDL Tirze 30 remove | ||||||||||
| Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ||||||||||
| SKU | IN_LK-8 | IN_LK-9 | IN_LK-2 | IN_LK-3 | IN_LK-13 | |||||||||||
| Rating | ||||||||||||||||
| Price | R650,00 | R2 800,00 | R2 100,00 | R1 800,00 | R3 600,00 | R2 100,00 | ||||||||||
| Stock | ||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Additional information |
|
|
|
|
| |||||||||||
| Description | DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of morbidity from other medical conditions is increased. P | Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide. | Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide. |
|
| Experience the dual-action power of Tirzepatide 30mg from The Clinic, a next-generation injectable peptide designed to target two key hormone pathways: GLP-1 and GIP. | ||||||||||
| Add to cart |

